Tech Company Financing Transactions

SEngine Precision Medicine Funding Round

SEngine Precision Medicine secured a $19 million Series A financing round on 7/28/2022. Backers included Washington Research Foundation, Alethea Capital and Bangarang.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

401 Terry Ave. N.
Seattle, WA 98109
USA

Phone

(833) 736-4163

Website

www.senginemedicine.com

Email Address

Not Recorded

Overview

SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 100 cancer drugs against a patient's unique tumor organoid outside the body.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Carla Grandori

        

Browse more venture capital transactions:

Prev: 7/28/2022: Space and Time venture capital transaction
Next: 7/28/2022: Humanloop venture capital transaction

Share this article

About Database of VC Transactions

We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary